Search
for
Sort by
Research 361–390 of 1000+
- SARS‐COV2 Vaccination and Hidradenitis Suppurativa: Role of Vaccination in Disease Activity
- Identifying SARS-CoV-2 entry inhibitors through drug repurposing screens of SARS-S and MERS-S pseudotyped particles
- 5-Alpha-Reductase Inhibitors Reduce Remission Time of COVID-19: Results From a Randomized Double Blind Placebo Controlled Interventional Trial in 130 SARS-CoV-2 Positive Men
- Anti-SARS-CoV-2 Action of 5α-Reductase Inhibitors May Be Mediated by Dehydroepiandrosterone. Letter.
- Post SARS-CoV-2 vaccination effluvium
- Asymptomatic SARS-COV2 Infection or COVID-19 vaccination effect for severe multisystem inflammatory syndrome in a 6-year-old girl: case report and review of the literature
- Immunoreactivity of the SARS-CoV-2 entry proteins ACE-2 and TMPRSS-2 in murine models of hormonal manipulation, ageing, and cardiac injury
- Study of SARS-CoV-2 in semen and urine samples of a volunteer with positive naso-pharyngeal swab
- Comparison of viral RNA–host protein interactomes across pathogenic RNA viruses informs rapid antiviral drug discovery for SARS-CoV-2
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- Structural insights into SARS-CoV-2 spike protein and its natural mutants found in Mexican population
- Role of testosterone in SARS-CoV-2 infection: A key pathogenic factor and a biomarker for severe pneumonia
- Spiking dependence of SARS‐CoV‐2 pathogenicity on TMPRSS2
- Candidate genes of SARS-CoV-2 gender susceptibility
- Basic mechanisms of SARS-CoV-2 infection. What endocrine systems could be implicated?
- Saying no to SARS-CoV-2: the potential of nitric oxide in the treatment of COVID-19 pneumonia
- Sex hormones in SARS-CoV-2 susceptibility: key players or confounders?
- Vaccines Against SARS-CoV-2 in Psoriasis Patients on Immunosuppressive Therapy: Implications of Vaccination Nationwide Campaign on Clinical Practice in Italy
- Clomipramine suppresses ACE2-mediated SARS-CoV-2 entry
- Telogen effluvium in SARS‐CoV‐2 infection: Histological aspects
- Intra-host SARS-CoV-2 single-nucleotide variants emerged during the early stage of COVID-19 pandemic forecast population fixing mutations
- Evaluation of SARS-CoV-2 Entry, Inflammation and New Therapeutics in Human Lung Tissue Cells
- Evaluation of SARS-CoV-2 entry, inflammation and new therapeutics in human lung tissue cells
- NOVEL CORONAVIRUS (SARS-COV-2): MOLECULAR BIOLOGY, PATHOGENESIS, PATHOBIOLOGY AND ADVANCES IN TREATMENT OF COVID-19 PATIENTS– AN UPDATE
- Severe Acute SARS-CoV-2 Infection and Long COVID: What Do We Know So Far? New Challenges in Diagnosis and Management
- Hair loss after SARS-CoV2 Infection
- Evaluating cepharanthine analogues as natural drugs against SARS‐CoV‐2
- Network-based identification genetic effect of SARS-CoV-2 infections to Idiopathic pulmonary fibrosis (IPF) patients
- Medical education and care in dermatology during the SARS‐CoV2 pandemia: challenges and chances
- Virtual Screening of Potential Inhibitors for SARS-CoV-2 Main Protease